| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 158.06% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 05/04/2023 | 222.58% | HC Wainwright & Co. | $16 → $10 | Reiterates | → Buy |
| 05/04/2023 | 125.81% | Alliance Global Partners | $14.5 → $7 | Maintains | Buy |
| 02/10/2023 | 416.13% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 02/10/2023 | 367.74% | Alliance Global Partners | $16.5 → $14.5 | Maintains | Buy |
| 11/04/2022 | 432.26% | Alliance Global Partners | $17.5 → $16.5 | Maintains | Buy |
| 05/06/2022 | 416.13% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy |
| 03/03/2022 | 319.35% | HC Wainwright & Co. | $12 → $13 | Maintains | Buy |
| 02/14/2022 | 287.1% | HC Wainwright & Co. | $10 → $12 | Maintains | Buy |
| 12/02/2021 | 222.58% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 11/05/2021 | 190.32% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/06/2021 | 125.81% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/01/2021 | 93.55% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 02/26/2021 | 93.55% | Roth Capital | $4 → $6 | Maintains | Buy |
| 11/09/2020 | 29.03% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 05/11/2020 | -3.23% | B. Riley Securities | $5.5 → $3 | Maintains | Neutral |
| 05/08/2020 | 61.29% | HC Wainwright & Co. | $8 → $5 | Reiterates | → Buy |
| 11/07/2019 | 77.42% | B. Riley Securities | $14 → $5.5 | Downgrades | Buy → Neutral |
| 09/19/2018 | 222.58% | Maxim Group | $9 → $10 | Maintains | Buy |
| 08/27/2018 | 351.61% | HC Wainwright & Co. | → $14 | Initiates Coverage On | → Buy |
What is the target price for Sensus Healthcare (SRTS)?
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $8.00 expecting SRTS to rise to within 12 months (a possible 158.06% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by HC Wainwright & Co., and Sensus Healthcare maintained their buy rating.
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a maintained with a price target of $10.00 to $8.00. The current price Sensus Healthcare (SRTS) is trading at is $3.10, which is out of the analyst's predicted range.